This cumulative thesis evaluates opportunities, to integrate high-throughput and model-based technologies in biopharmaceutical protein purification
The development of biopharmaceutical downstream processes relies on exhaustive experimental studies....
While regulatory agencies require stringent product quality and safety to be upheld in biopharmaceut...
An integrated experimental and modeling approach for the design of high productivity protein A chrom...
While the integration of PAT is already well-advanced in upstream processing of therapeutic proteins...
Erworben im Rahmen der Schweizer Nationallizenzen (http://www.nationallizenzen.ch
Engineered plant cells can be used in order to produce antibodies. Suitable methods for process deve...
Peptidmicroarrays, bestehend aus einer großen Vielfalt unterschiedlicher Peptide auf einer festen Ob...
Introduction: In an increasingly competitive global market, it is vital to find new ways to reduce d...
The production of monoclonal antibodies and Fc fusion proteins form the largest and most rapidly exp...
The focus of this thesis is laid on the implementation of integrated bioprocesses and the developmen...
Proteins are the building blocks of all living organisms enabling us to function and survive. There ...
Chromatography remains the workhorse in antibody purification; however process development and char...
This thesis consists of nine publications and manuscripts that focus on different aspects of chromat...
Aktuelle Trends in der pharmazeutischen Industrie verändern den Weg der Proteinreinigungsprozesse. I...
Biopharmaceutics are used for therapy of human diseases. Requiring high purity, their downstream pro...
The development of biopharmaceutical downstream processes relies on exhaustive experimental studies....
While regulatory agencies require stringent product quality and safety to be upheld in biopharmaceut...
An integrated experimental and modeling approach for the design of high productivity protein A chrom...
While the integration of PAT is already well-advanced in upstream processing of therapeutic proteins...
Erworben im Rahmen der Schweizer Nationallizenzen (http://www.nationallizenzen.ch
Engineered plant cells can be used in order to produce antibodies. Suitable methods for process deve...
Peptidmicroarrays, bestehend aus einer großen Vielfalt unterschiedlicher Peptide auf einer festen Ob...
Introduction: In an increasingly competitive global market, it is vital to find new ways to reduce d...
The production of monoclonal antibodies and Fc fusion proteins form the largest and most rapidly exp...
The focus of this thesis is laid on the implementation of integrated bioprocesses and the developmen...
Proteins are the building blocks of all living organisms enabling us to function and survive. There ...
Chromatography remains the workhorse in antibody purification; however process development and char...
This thesis consists of nine publications and manuscripts that focus on different aspects of chromat...
Aktuelle Trends in der pharmazeutischen Industrie verändern den Weg der Proteinreinigungsprozesse. I...
Biopharmaceutics are used for therapy of human diseases. Requiring high purity, their downstream pro...
The development of biopharmaceutical downstream processes relies on exhaustive experimental studies....
While regulatory agencies require stringent product quality and safety to be upheld in biopharmaceut...
An integrated experimental and modeling approach for the design of high productivity protein A chrom...
DOI
Add to ORKG